Zensar Technologies Ltd
Zensar Technologies Ltd
Information TechnologyKey Fundamentals
MicrocapComputer Software & ConsultingInformation TechnologyInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Zensar Technologies Ltd insights
62 extracted metrics + investor summaries across FY11–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
6- Company has reduced debt.
- Company is almost debt free.
- Stock is providing a good dividend yield of 3.06%.
- Company has delivered good profit growth of 18.2% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 40.0%
- Company's working capital requirements have reduced from 25.7 days to 19.9 days
Weaknesses
1- The company has delivered a poor sales growth of 8.51% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Zensar Technologies is a mid-cap IT services company with a market cap of ₹12,061 Cr trading at a PE of 15.1x. The company has delivered strong profit growth (18% CAGR over 5 years) and maintains a near debt-free balance sheet, but revenue growth has been tepid at 8.5% over five years and the stock has declined 36% over the past year.
- Company is virtually debt-free, providing financial flexibility and resilience during downturns
- Strong compounded profit growth of 18% CAGR over 5 years and 34% CAGR over 3 years indicates improving profitability
- Healthy dividend payout ratio of 40% with a current dividend yield of 2.91%, well above IT sector average
- PE ratio of 15.1x is significantly below mid-cap IT sector peers, suggesting potential valuation comfort
- Consistent ROE of 16-18% over 3, 5, and 10-year periods reflects disciplined capital allocation
- Working capital days reduced from 25.7 to 19.9 days, indicating improving cash conversion efficiency
- TTM profit growth of 24% outpacing TTM sales growth of 8%, showing margin expansion capability
- Stock has declined 36% over the past 1 year, significantly underperforming the broader market and IT index
- Tepid revenue growth of only 8.5% CAGR over 5 years and 5% over 3 years in a sector where peers are growing faster
- 10-year stock CAGR of just 9% suggests prolonged underperformance relative to broader indices
- TTM sales growth of 8% remains below double digits, raising concerns about demand environment and deal wins
- 3-year stock CAGR of only 2% indicates the market has not rewarded the profit growth with commensurate re-rating
- Compounded sales growth has decelerated from 9% (5-year) to 5% (3-year), suggesting a slowing trajectory
- Small market cap of ₹12,061 Cr limits scale advantages compared to larger IT peers competing for the same deals
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- EBITDA margin contracts on deal costs Jul 31
EBITDA margin contracted to 14.6% in Q1FY27 due to large deal transition costs, pressuring near-term profitability despite revenue growth.
- Net profit growth nearly flat Jul 31
Q1FY27 net profit of ₹1,838 million grew only 1% YoY, significantly lagging the 8.9% revenue growth, indicating margin headwinds.
- Revenue up 8.9% YoY in Q1 Jul 31
Q1FY27 consolidated revenue reached ₹15,083 million, up 8.9% YoY with BFSI vertical leading growth.
- Strong ESG progress filed Jul 8
BRSR for FY26 reports 56.5% reduction in Scope 1 and 2 emissions and 60.2% renewable energy share, strengthening ESG credentials.
- ESOP grant signals retention focus Jul 21
Granted 6,28,502 ESOP options at ₹2 exercise price on July 20, 2026, aimed at retaining key talent.
- Final dividend of ₹12.60/share Jul 8
Board proposed final dividend of INR 12.60 per share for FY26, to be approved at the 63rd AGM on July 30, 2026.
- Bridgeview merger effective Aug 1 Jul 31
Merger of Bridgeview Life Sciences LLC into Zensar Technologies Inc. effective August 1, 2026, with no change in shareholding or cash consideration — purely internal US subsidiary restructuring.
- 63rd AGM held, RPTs approved Jul 30
AGM concluded on July 30, 2026, approving FY26 audited financials and material related party transactions with the South African subsidiary.
- Q1FY27 earnings call recording released Jul 30
Audio recording of the Q1FY27 earnings call held on July 30, 2026 published on the investor relations website.
TL;DR: Zensar delivered healthy 8.9% YoY revenue growth in Q1FY27 led by BFSI, but profitability is under pressure with EBITDA margin contracting to 14.6% due to large deal transition costs and net profit barely growing. ESG credentials and shareholder returns (₹12.60 dividend) are solid positives. The key forward-looking question is whether large deal ramp-ups will translate into margin recovery in coming quarters as transition costs normalize.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,227 | 1,241 | 1,204 | 1,230 | 1,288 | 1,308 | 1,326 | 1,359 | 1,385 | 1,421 | 1,431 | 1,450 | 1,508 |
| Expenses | 997 | 1,010 | 996 | 1,027 | 1,092 | 1,107 | 1,119 | 1,146 | 1,174 | 1,201 | 1,181 | 1,215 | 1,287 |
| Operating Profit | 230 | 231 | 208 | 203 | 196 | 201 | 207 | 212 | 211 | 220 | 250 | 236 | 221 |
| OPM % | 19% | 19% | 17% | 17% | 15% | 15% | 16% | 16% | 15% | 15% | 17% | 16% | 15% |
| Other Income | 28 | 36 | 42 | 52 | 42 | 41 | 31 | 46 | 57 | 49 | 38 | 66 | 57 |
| Interest | 6 | 6 | 6 | 3 | 4 | 4 | 4 | 5 | 4 | 4 | 2 | 2 | 4 |
| Depreciation | 42 | 37 | 31 | 24 | 25 | 30 | 24 | 24 | 23 | 25 | 20 | 23 | 28 |
| PBT | 210 | 225 | 212 | 229 | 210 | 208 | 210 | 230 | 241 | 240 | 265 | 276 | 246 |
| Tax % | 26% | 23% | 24% | 24% | 25% | 25% | 24% | 23% | 24% | 24% | 25% | 24% | 25% |
| Net Profit | 156 | 174 | 162 | 173 | 158 | 156 | 160 | 176 | 182 | 182 | 200 | 211 | 184 |
| EPS in Rs | 6.9 | 7.68 | 7.14 | 7.65 | 6.97 | 6.86 | 7.04 | 7.77 | 8.01 | 8.01 | 8.79 | 9.26 | 8.08 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,656 | 2,952 | 3,056 | 3,108 | 3,966 | 4,182 | 3,781 | 4,244 | 4,848 | 4,902 | 5,281 | 5,687 | 5,811 |
| Expenses | 2,264 | 2,513 | 2,674 | 2,743 | 3,487 | 3,675 | 3,097 | 3,587 | 4,296 | 4,030 | 4,464 | 4,771 | 4,884 |
| Operating Profit | 392 | 439 | 382 | 365 | 479 | 507 | 685 | 656 | 552 | 872 | 817 | 916 | 926 |
| OPM % | 15% | 15% | 12% | 12% | 12% | 12% | 18% | 15% | 11% | 18% | 15% | 16% | 16% |
| Other Income | 27 | 54 | 24 | 74 | 93 | 88 | -24 | 138 | 103 | 159 | 160 | 209 | 210 |
| Interest | 11 | 11 | 9 | 23 | 37 | 61 | 54 | 35 | 28 | 21 | 17 | 12 | 12 |
| Depreciation | 42 | 65 | 49 | 65 | 89 | 159 | 175 | 185 | 183 | 134 | 102 | 91 | 97 |
| PBT | 366 | 417 | 349 | 352 | 445 | 376 | 433 | 574 | 444 | 876 | 858 | 1,022 | 1,027 |
| Tax % | 28% | 30% | 32% | 30% | 28% | 28% | 29% | 27% | 26% | 24% | 24% | 24% | — |
| Net Profit | 265 | 292 | 238 | 246 | 319 | 272 | 307 | 422 | 328 | 665 | 650 | 775 | 776 |
| EPS in Rs | 11.94 | 12.97 | 10.47 | 10.74 | 13.93 | 11.69 | 13.3 | 18.4 | 14.47 | 29.34 | 28.61 | 34.05 | 34.14 |
| Div. Payout % | 18% | 18% | 23% | 22% | 20% | 24% | 27% | 27% | 35% | 31% | 45% | 44% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 1,113 | 1,220 | 1,427 | 1,624 | 1,897 | 2,045 | 2,297 | 2,642 | 2,931 | 3,517 | 4,024 | 4,674 |
| Borrowings | 176 | 149 | 134 | 9 | 300 | 332 | 350 | 335 | 273 | 186 | 125 | 79 |
| Other Liabilities | 402 | 455 | 500 | 618 | 847 | 1,174 | 742 | 817 | 872 | 899 | 978 | 1,274 |
| Total Liabilities | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 5,173 | 6,072 |
| Fixed Assets | 547 | 386 | 447 | 592 | 950 | 1,323 | 1,133 | 1,254 | 1,174 | 1,034 | 1,170 | 1,223 |
| CWIP | 1 | 2 | 3 | 6 | 12 | 11 | 0 | 1 | 0 | 5 | 1 | 176 |
| Investments | 94 | 134 | 243 | 275 | 115 | 278 | 517 | 324 | 899 | 1,408 | 1,714 | 1,921 |
| Other Assets | 1,092 | 1,347 | 1,413 | 1,424 | 2,013 | 1,983 | 1,783 | 2,260 | 2,049 | 2,200 | 2,288 | 2,753 |
| Total Assets | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 5,173 | 6,072 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 321 | 255 | 304 | 206 | 156 | 686 | 858 | 336 | 714 | 642 | 565 | 771 |
| Investing | -182 | -41 | -204 | -142 | -229 | -315 | -530 | 3 | -527 | -476 | -473 | -224 |
| Financing | -87 | -129 | -50 | -204 | 201 | -197 | -467 | -183 | -219 | -197 | -264 | -401 |
| Net Cash Flow | 51 | 85 | 50 | -140 | 128 | 175 | -139 | 156 | -31 | -31 | -172 | 146 |
| Free Cash Flow | 283 | 212 | 269 | 154 | 104 | 608 | 819 | 279 | 681 | 627 | 530 | 719 |
| CFO/OP | 107 | 82 | 107 | 85 | 61 | 158 | 146 | 74 | 146 | 100 | 96 | 105 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 67 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 | 55 | 59 |
| Inventory Days | 266 | 304 | — | — | — | — | — | — | — | — | — | — |
| Days Payable | 283 | 400 | — | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 45 | -29 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 | 55 | 59 |
| Working Capital Days | 41 | 56 | 49 | 70 | 57 | 20 | 19 | 36 | 21 | 27 | 30 | 20 |
| ROCE % | 30% | 31% | 24% | 23% | 23% | 18% | 21% | 21% | 15% | 25% | 21% | 23% |
Documents
Frequently Asked Questions about Zensar Technologies Ltd
What does Zensar Technologies Ltd do?
Where is Zensar Technologies Ltd (ZENSARTECH) listed?
Which sector does Zensar Technologies Ltd belong to?
What is the market capitalisation of Zensar Technologies Ltd?
What is the PE ratio of Zensar Technologies Ltd?
What is the 52-week high and low of Zensar Technologies Ltd?
Does Zensar Technologies Ltd pay dividends?
What is the Return on Equity (ROE) of Zensar Technologies Ltd?
How can I research Zensar Technologies Ltd on Tapetide?
Company Information
Zensar Technologies is a leading digital solutions and technology services company. It is a part of the Mumbai-based RPG group and is headquartered in Pune, India. It operates in two segments: Application Management Service and Infrastructure management service. It is focused on industry verticals, such as Hitech & manufacturing, consumer services, and banking, financial services, and insurance. They have offices located in India, the USA, UK, Europe, and Africa. [1] [2]